Pharmacogenomics & Personalized Medicine

Papers
(The H4-Index of Pharmacogenomics & Personalized Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy27
Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China25
Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis21
Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP18
One Rare Warfarin Resistance Case and Possible Mechanism Exploration17
Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population14
Genetic Variations of CARMN Modulate Glioma Susceptibility and Prognosis in a Chinese Han Population14
The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review14
Clinical Characteristics and Gene Mutations of Two Families with MODY 3 in Inner Mongolia13
Correlation Between Angiotensin Receptor Type 1 Polymorphisms and Atherosclerotic Cerebral Infarction Risk11
The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review10
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer10
Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK1410
0.12646102905273